Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Can J Cardiol ; 31(1): 3-16, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25532421

ABSTRACT

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides discussion on the management recommendations on 3 focused areas: (1) anemia; (2) biomarkers, especially natriuretic peptides; and (3) clinical trials that might change practice in the management of patients with heart failure. First, all patients with heart failure and anemia should be investigated for reversible causes of anemia. Second, patients with chronic stable heart failure should undergo natriuretic peptide testing. Third, considerations should be given to treat selected patients with heart failure and preserved systolic function with a mineralocorticoid receptor antagonist and to treat patients with heart failure and reduced ejection fraction with an angiotensin receptor/neprilysin inhibitor, when the drug is approved. As with updates in previous years, the topics were chosen in response to stakeholder feedback. The 2014 Update includes recommendations, values and preferences, and practical tips to assist the clinicians and health care workers to best manage patients with heart failure.


Subject(s)
Anemia/prevention & control , Biomarkers/blood , Cardiology/organization & administration , Heart Failure/diagnosis , Societies, Medical/organization & administration , Anemia/blood , Angiotensin Receptor Antagonists/therapeutic use , Blood Pressure , Canada , Clinical Trials as Topic , Heart Failure/blood , Heart Failure/drug therapy , Humans , Mineralocorticoid Receptor Antagonists/therapeutic use , Neprilysin/antagonists & inhibitors
2.
Can J Cardiol ; 30(3): 249-63, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24480445

ABSTRACT

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides focused discussions on the management recommendations on 2 topics: (1) exercise and rehabilitation; and (2) surgical coronary revascularization in patients with heart failure. First, all patients with stable New York Heart Association class I-III symptoms should be considered for enrollment in a tailored exercise training program, to improve exercise tolerance and quality of life. Second, selected patients with suitable coronary anatomy should be considered for bypass graft surgery. As in previous updates, the topics were chosen in response to stakeholder feedback. The 2013 Update also includes recommendations, values and preferences, and practical tips to assist the clinicians and health care workers manage their patients with heart failure.


Subject(s)
Cardiology , Exercise Therapy/statistics & numerical data , Heart Failure/therapy , Myocardial Revascularization/standards , Practice Guidelines as Topic , Societies, Medical , Canada , Disease Management , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...